ALDH2 and Parkinson disease: Although there have not been in vitro results to prove the hypothesis, this finding suggests a novel mechanism for the interaction between COMT and ALDH2 in the pathogenesis of PD—development of neurotoxicity resulting from an imbalance in the pathway metabolizing monoamine neurotransmitter neurotoxic metabolites.